CERIANNA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Zionexa Us Corporation. The primary component is Fluoroestradiol F-18.
| Product ID | 72874-001_b47e1c0b-1d74-7b1d-e053-2995a90aded8 |
| NDC | 72874-001 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CERIANNA |
| Generic Name | Fluoroestradiol F 18 |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-05-20 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212155 |
| Labeler Name | Zionexa US Corporation |
| Substance Name | FLUOROESTRADIOL F-18 |
| Active Ingredient Strength | 100 mCi/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-05-20 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212155 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-05-20 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CERIANNA 88625202 not registered Live/Pending |
ZIONEXA 2019-09-20 |